Angry Anger Disappointed Las Cute  - suethomas / Pixabay

Amyris Taps the Market Again!

This morning, Amyris (AMRS) surprised investors by announcing the commencement of a proposed underwritten public offering of shares of its common stock. Current stockholders plan to offer $150 million of shares and the company intends to offer an additional $100 million. J.P. Morgan Securities LLC and Cowen and Company, LLC are acting as the joint […]

Read More »

Amyris is Starting to Execute

Amyris AMRS (disclosure: long) has closed the first of several announced transactions that should eliminate all debt problems and show investors that management can be trusted. EMERYVILLE, Calif., Dec. 21, 2020 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of […]

Read More »

Amyris Setting up For a Run

Seeking Alpha has published a great article on biotechnology company AMRS explaining why the stock is up 100% since the beginning of November. Amyris is currently in the final stages of negotiating 3 major transactions, expecting to net the company over $450M. The first one is expected to close in December and provide $30M cash […]

Read More »